BNP/CALL/STRYKER CORP./380/0.1/17.01.25 Share Price

Warrant

DE000PN5BB07

Delayed Deutsche Boerse AG 01:20:38 27/06/2024 pm IST
1.04 EUR -2.80% Intraday chart for BNP/CALL/STRYKER CORP./380/0.1/17.01.25
Current month-9.32%
1 month-2.73%
Date Price Change
27/24/27 1.04 -2.80%
26/24/26 1.07 +5.94%
25/24/25 1.01 -5.61%
24/24/24 1.07 -7.76%
21/24/21 1.16 +0.87%

Delayed Quote Deutsche Boerse AG

Last update June 27, 2024 at 01:20 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PN5BB0
ISINDE000PN5BB07
Date issued 27/06/2023
Strike 380 $
Maturity 17/01/2025 (205 Days)
Parity 10 : 1
Emission price 1.11
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.78
Lowest since issue 0.37
Spread 0.05
Spread %4.59%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
340.5 USD
Average target price
372.9 USD
Spread / Average Target
+9.52%
Consensus